Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    February 2017
  1. LI J, Yousefi K, Ding W, Singh J, et al
    Osteopontin RNA Aptamer Can Prevent and Reverse Pressure Overload-Induced Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


  2. GRECO S, Zaccagnini G, Fuschi P, Voellenkle C, et al
    Increased Bace1-As Long Noncoding Rna And beta-Amyloid Levels In Heart Failure.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


  3. ELIA L, Quintavalle M, Condorelli G
    Circular RNAs and heart failure: new players for an old disease.
    Cardiovasc Res. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    


    January 2017
  4. NONHOFF J, Ricke-Hoch M, Mueller M, Stapel B, et al
    Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Cardiovasc Res. 2017 Jan 20. pii: cvw245. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2016
  5. LI L, Li J, Drum BM, Chen Y, et al
    Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


    July 2016
  6. TAKADA S, Masaki Y, Kinugawa S, Matsumoto J, et al
    Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of GLP-1 receptor signaling.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  7. LIU L, An X, Li Z, Song Y, et al
    The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;111:56-65.
    PubMed     Text format     Abstract available


  8. SCHEID LM, Mosqueira M, Hein S, Kossack M, et al
    Essential light chain S195 phosphorylation is required for cardiac adaptation under physical stress.
    Cardiovasc Res. 2016;111:44-55.
    PubMed     Text format     Abstract available


    June 2016
  9. BOOIJ HG, Yu H, de Boer RA, van de Kolk CW, et al
    Overexpression of A kinase interacting protein 1 attenuates myocardial ischemia / reperfusion injury, but does not influence heart failure development.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  10. HILLE S, Dierck F, Kuhl C, Sosna J, et al
    Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
    Cardiovasc Res. 2016;110:381-94.
    PubMed     Text format     Abstract available


    May 2016
  11. GOGIRAJU R, Schroeter MR, Bochenek ML, Hubert A, et al
    Endothelial Deletion of Protein Tyrosine Phosphatase-1B Protects Against Pressure Overload-Induced Heart Failure in Mice.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  12. KOOIJ V, Viswanathan MC, Lee DI, Rainer PP, et al
    Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy.
    Cardiovasc Res. 2016;110:238-48.
    PubMed     Text format     Abstract available


    March 2016
  13. MASSENGILL MT, Ashraf HM, Chowdhury RR, Chrzanowski SM, et al
    Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


  14. BYRNE NJ, Levasseur J, Sung MM, Masson G, et al
    Normalization of Cardiac Substrate Utilization and Left Ventricular Hypertrophy Precede Functional Recovery in Heart Failure Regression.
    Cardiovasc Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  15. GOH KY, Qu J, Hong H, Liu T, et al
    Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes.
    Cardiovasc Res. 2016;109:79-89.
    PubMed     Text format     Abstract available


    December 2015
  16. KUMAGAI S, Nakayama H, Fujimoto M, Honda H, et al
    Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  17. MAACK C
    Orphaned mitochondria in heart failure.
    Cardiovasc Res. 2015.
    PubMed     Text format    


    September 2015
  18. LUCAS A, Mialet-Perez J, Daviaud D, Parini A, et al
    Gadd45gamma regulates cardiomyocytes death and post-myocardial infarction left ventricular remodelling.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


    June 2015
  19. FERT-BOBER J, Giles JT, Holewinski RJ, Kirk JA, et al
    Citrullination of myofilament proteins in heart failure.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


  20. HAUBNER BJ, Moik D, Schuetz T, Reiner MF, et al
    In vivo cardiac role of migfilin during experimental pressure overload.
    Cardiovasc Res. 2015;106:398-407.
    PubMed     Text format     Abstract available


    May 2015
  21. YABLUCHANSKIY A, Ma Y, Lindsey ML
    Syndecan-4: a novel regulator of collagen synthesis and deposition in the pressure-overloaded myocardium.
    Cardiovasc Res. 2015;106:178-9.
    PubMed     Text format    


  22. SEYMOUR AM, Giles L, Ball V, Miller JJ, et al
    In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy.
    Cardiovasc Res. 2015;106:249-60.
    PubMed     Text format     Abstract available


  23. HERUM KM, Lunde IG, Skrbic B, Louch WE, et al
    Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
    Cardiovasc Res. 2015;106:217-26.
    PubMed     Text format     Abstract available


    April 2015
  24. DUBOIS-DERUY E, Belliard A, Mulder P, Bouvet M, et al
    Interplay between troponin T phosphorylation and O-N-acetylglucosaminylation in ischaemic heart failure.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


  25. DI LISA F, Itoh N
    Cardiac Fgf21 synthesis and release: an autocrine loop for boosting up antioxidant defenses in failing hearts.
    Cardiovasc Res. 2015;106:1-3.
    PubMed     Text format    


  26. SKRBIC B, Engebretsen KV, Strand ME, Lunde IG, et al
    Lack of collagen VIII reduces fibrosis and promotes early mortality and cardiac dilatation in pressure overload in mice.
    Cardiovasc Res. 2015;106:32-42.
    PubMed     Text format     Abstract available


  27. PLANAVILA A, Redondo-Angulo I, Ribas F, Garrabou G, et al
    Fibroblast growth factor 21 protects the heart from oxidative stress.
    Cardiovasc Res. 2015;106:19-31.
    PubMed     Text format     Abstract available


    March 2015
  28. ABDURRACHIM D, Luiken JJ, Nicolay K, Glatz JF, et al
    Good and bad consequences of altered fatty acid metabolism in heart failure: Evidence from mouse models.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


  29. XU X, Tan X, Tampe B, Nyamsuren G, et al
    Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis.
    Cardiovasc Res. 2015;105:279-91.
    PubMed     Text format     Abstract available


    January 2015
  30. JACOBS G, Oosterlinck W, Dresselaers T, Geenens R, et al
    Enhanced beta-adrenergic cardiac reserve in Trpm4-/- mice with ischemic heart failure.
    Cardiovasc Res. 2015.
    PubMed     Text format     Abstract available


  31. BOSSUYT J
    Nuclear remodelling: a consequence of nucleocytoplasmic traffic run amok?
    Cardiovasc Res. 2015;105:6-7.
    PubMed     Text format    


  32. SEIDEL M, Thomas NL, Williams AJ, Lai FA, et al
    Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors.
    Cardiovasc Res. 2015;105:118-28.
    PubMed     Text format     Abstract available


  33. CHAHINE MN, Mioulane M, Sikkel MB, O'Gara P, et al
    Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts.
    Cardiovasc Res. 2015;105:31-43.
    PubMed     Text format     Abstract available


    October 2014
  34. BANDARU S, Gronros J, Redfors B, Cil C, et al
    Deficiency of filamin A in endothelial cells impairs left ventricular remodeling after myocardial infarction.
    Cardiovasc Res. 2014.
    PubMed     Text format     Abstract available


    July 2014
  35. WESTERMANN D, Heymans S
    Fibrosis or hypertrophy: let TIMPs decide.
    Cardiovasc Res. 2014;103:196-7.
    PubMed     Text format    


  36. FAN D, Takawale A, Basu R, Patel V, et al
    Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Cardiovasc Res. 2014;103:268-80.
    PubMed     Text format     Abstract available


  37. ZHU W, Zhang W, Shou W, Field LJ, et al
    P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.
    Cardiovasc Res. 2014;103:81-9.
    PubMed     Text format     Abstract available


  38. MATHIYALAGAN P, Keating ST, Du XJ, El-Osta A, et al
    Chromatin modifications remodel cardiac gene expression.
    Cardiovasc Res. 2014;103:7-16.
    PubMed     Text format     Abstract available


    June 2014
  39. WU CT, Qi XY, Huang H, Naud P, et al
    Disease and region-related cardiac fibroblast potassium current variations and potential functional significance.
    Cardiovasc Res. 2014;102:487-96.
    PubMed     Text format     Abstract available


    May 2014
  40. VAN LINTHOUT S, Miteva K, Tschope C
    Crosstalk between fibroblasts and inflammatory cells.
    Cardiovasc Res. 2014;102:258-69.
    PubMed     Text format     Abstract available


  41. FUJIU K, Wang J, Nagai R
    Cardioprotective function of cardiac macrophages.
    Cardiovasc Res. 2014;102:232-9.
    PubMed     Text format     Abstract available


  42. VIERECK J, Bang C, Foinquinos A, Thum T, et al
    Regulatory RNAs and paracrine networks in the heart.
    Cardiovasc Res. 2014;102:290-301.
    PubMed     Text format     Abstract available


    March 2014
  43. XIAO D, Dasgupta C, Chen M, Zhang K, et al
    Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats.
    Cardiovasc Res. 2014;101:373-82.
    PubMed     Text format     Abstract available


  44. PETERFI Z, Toth ZE, Kovacs HA, Lazar E, et al
    Peroxidasin-like protein: a novel peroxidase homologue in the human heart.
    Cardiovasc Res. 2014;101:393-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: